# The amino acid transporter LAT1 coordinates proper motor function at the perinatal stage

**Authors:** Koki Sadamori, Manami Hiraiwa, Tetsuhiro Horie, Kazuya Tokumura, Kazuya Fukasawa, Kentaro Sahashi, Soji Hayashida, Takuya Kubo, Makoto Yoshimoto, Shohei Tsuji, Yasuhito Ishigaki, Masahisa Katsuno, Eiichi Hinoi

PMC · DOI: 10.1038/s41419-026-08663-8 · Cell Death & Disease · 2026-03-24

## TL;DR

A transporter called LAT1 is crucial for motor neuron development and coordination in young mice, and its absence leads to severe motor issues and early death.

## Contribution

Identifies LAT1's essential role in motor circuit development and suggests it as a potential therapeutic target for motor neuron diseases.

## Key findings

- Mice lacking LAT1 in Syn1-expressing neurons show motor coordination deficits and early postnatal death.
- LAT1 deficiency causes lower motor neuron degeneration and neuromuscular junction maldevelopment.
- Pharmacological inhibition of apoptosis improves survival and reduces motor neuron loss in LAT1-deficient mice.

## Abstract

L-type amino acid transporter 1 (LAT1, encoded by Slc7a5) contributes to amino acid homeostasis and signaling in numerous cell types. Several lines of evidence implicate LAT1 in mammalian central nervous system development, but its functional significance in specific neuronal subtypes is largely unknown. Here, we demonstrate that LAT1/Slc7a5 expression in synapsin 1 (Syn1)-expressing neurons is essential for motor circuit development and motor coordination at the perinatal stage. Mice lacking Slc7a5 in Syn1-expressing neurons exhibited progressive motor coordination deficits and early postnatal lethality. These deficits were associated with selective degeneration of lower spinal motor neurons, reactive gliosis, skeletal muscle atrophy, and maldevelopment of neuromuscular junctions (NMJs), but no abnormalities in gross brain structure or neuronal viability. Pharmacological inhibition of apoptosis prolonged the survival of Slc7a5-deficient mice and reduced both lower motor neuron loss and NMJ maldevelopment. Furthermore, multi-cohort transcriptome analyses revealed inactivation of amino acid transport activity along with the downregulation of Slc7a5 expression in motor neurons of spinal muscular atrophy model mice. These results suggest that the amino acid transport system is essential for the survival and function of lower spinal motor neurons during early postnatal development, and identifies LAT1 as a potential therapeutic target for early-onset motor neuron diseases.

## Linked entities

- **Genes:** SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140], SYN1 (synapsin I) [NCBI Gene 6853]
- **Proteins:** SLC7A5 (solute carrier family 7 member 5), SYN1 (synapsin I)
- **Diseases:** spinal muscular atrophy (MONDO:0001516)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Lat (linker for activation of T cells) [NCBI Gene 16797] {aka p36-38, pp36}, Lepr (leptin receptor) [NCBI Gene 16847] {aka B219, LEP-R, LEPROT, Leprb, Modb1, OB-RGRP}, Chat (choline O-acetyltransferase) [NCBI Gene 12647] {aka B230380D24Rik, CHOACTase}, Lat2 (linker for activation of T cells family, member 2) [NCBI Gene 56743] {aka LAB, NTAL, WSCR5, Wbscr15, Wbscr5}, Slc7a5 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 5) [NCBI Gene 20539] {aka 4F2LC, D0H16S474E, Gm42049, LAT1, TA1}, Emx1 (empty spiracles homeobox 1) [NCBI Gene 13796], Slc43a1 (solute carrier family 43, member 1) [NCBI Gene 72401] {aka 2610016F07Rik, Lat3, PB39, Pov1, R00504}, SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140] {aka 4F2LC, CD98, D16S469E, E16, LAT1, MPE16}, Syp (synaptophysin) [NCBI Gene 20977] {aka A230093K24Rik, Syn, p38}, Syn1 (synapsin I) [NCBI Gene 20964] {aka Syn-1, Syn1-S}, Aif1 (allograft inflammatory factor 1) [NCBI Gene 11629] {aka AIF-1, D17H6S50E, G1, Iba1}, Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, Smn1 (survival motor neuron 1) [NCBI Gene 20595] {aka Gemin1, Smn}, Rbfox3 (RNA binding protein, fox-1 homolog (C. elegans) 3) [NCBI Gene 52897] {aka Fox-3, Hrnbp3, NeuN, Neuna60}, Iba1 (induction of brown adipocytes 1) [NCBI Gene 114737], Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Slc7a8 (solute carrier family 7 (cationic amino acid transporter, y+ system), member 8) [NCBI Gene 50934] {aka LAT2}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Grm7 (glutamate receptor, metabotropic 7) [NCBI Gene 108073] {aka 6330570A01Rik, C030018L03, E130018M02Rik, Gpr1g, Gprc1g, SMN2}, Mag (myelin-associated glycoprotein) [NCBI Gene 17136] {aka Gma, siglec-4a}, Slc43a2 (solute carrier family 43, member 2) [NCBI Gene 215113] {aka 7630402D21Rik, Lat4}
- **Diseases:** neuromuscular dysfunction (MESH:D009468), ASD (MESH:D000067877), motor coordination deficits (MESH:D001259), metabolic and skeletal abnormalities (MESH:D008659), neurodevelopmental disorders (MESH:D002658), SMA (MESH:D009134), atrophy (MESH:D001284), hypoxia (MESH:D000860), NMJ dysfunction (MESH:D006331), abnormal gait (MESH:D020233), astrogliosis (MESH:D005911), cancer (MESH:D009369), weight loss (MESH:D015431), NMJ maldevelopment (MESH:C538059), muscle weakness (MESH:D018908), motor deficits (MESH:D009461), fatigue (MESH:D005221), maldevelopment of NMJs (MESH:D020511), muscle atrophy (MESH:D009133), underweight (MESH:D013851), microcephaly (MESH:D008831), brain damage (MESH:D001925), motor (MESH:D000068079), motor neuron degeneration (MESH:D009410), ALS (MESH:D000690), embryonic lethality (MESH:D020964), postural abnormalities (MESH:D054972), neurological and neuropsychiatric disorders (MESH:D009422), Motor neuron diseases (MESH:D016472), myelopathy (MESH:D013118), NMJ defects (MESH:D000013), Neurodegeneration (MESH:D019636)
- **Chemicals:** citrate (MESH:D019343), Na+ (MESH:D012964), isoleucine (MESH:D007532), 4',6-Diamidino-2-phenylindole, dihydrochloride (-), paraffin (MESH:D010232), calpeptin (MESH:C071482), TBS (MESH:D013725), Triton-X (MESH:D017830), H&amp;E (MESH:D006371), valine (MESH:D014633), amino acid (MESH:D000596), leucine (MESH:D007930), BCAAs (MESH:D000597), Alexa Fluor 546 (MESH:C481052), DAPI (MESH:C007293), paraformaldehyde (MESH:C003043), ATP (MESH:D000255), hematoxylin (MESH:D006416), water (MESH:D014867), Alexa Fluor 488 (MESH:C000711379), K (MESH:D011188)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Gallus gallus (bantam, species) [taxon 9031]
- **Cell lines:** SMN2tg — Mus musculus (Mouse), Embryonic stem cell (CVCL_9108), E-MTAB-3664 — Homo sapiens (Human), Transformed cell line (CVCL_1W86)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039311/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039311/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039311/full.md

---
Source: https://tomesphere.com/paper/PMC13039311